Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 4
2011 3
2012 4
2013 4
2014 2
2016 3
2017 6
2018 5
2019 6
2020 10
2021 5
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
Gouëffic Y, Torsello G, Zeller T, Esposito G, Vermassen F, Hausegger KA, Tepe G, Thieme M, Gschwandtner M, Kahlberg A, Schindewolf M, Sapoval M, Diaz-Cartelle J, Stavroulakis K; EMINENT Investigators. Gouëffic Y, et al. Circulation. 2022 Nov 22;146(21):1564-1576. doi: 10.1161/CIRCULATIONAHA.122.059606. Epub 2022 Oct 18. Circulation. 2022. PMID: 36254728 Free article. Clinical Trial.
EVOLUTION Study: 12-month results.
Bosiers M, Deloose K, Callaert J, Peeters P, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K, Wauters J. Bosiers M, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2019 Aug;60(4):490-495. doi: 10.23736/S0021-9509.19.10706-9. Epub 2019 Jan 28. J Cardiovasc Surg (Torino). 2019. PMID: 30698370 Clinical Trial.
Drug-eluting technologies in femoral artery lesions.
Deloose K, Lauwers K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P, Bosiers M. Deloose K, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2013 Apr;54(2):217-24. J Cardiovasc Surg (Torino). 2013. PMID: 23558657 Review.
Endovascular management of acute limb ischemia.
Peeters P, Verbist J, Keirse K, Deloose K, Bosiers M. Peeters P, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2010 Jun;51(3):329-36. J Cardiovasc Surg (Torino). 2010. PMID: 20523282 Review.
BeGraft Peripheral PMCF Study: 12-month results.
Deloose K, Bosiers M, Callaert J, Peeters P, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K. Deloose K, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2019 Apr;60(2):230-236. doi: 10.23736/S0021-9509.17.09916-5. Epub 2017 May 26. J Cardiovasc Surg (Torino). 2019. PMID: 28548472
Drug-eluting stents below the knee.
Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Peeters P. Bosiers M, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2011 Apr;52(2):231-4. J Cardiovasc Surg (Torino). 2011. PMID: 21460773 Review.
Are drug-eluting stents the future of SFA treatment?
Bosiers M, Deloose K, Keirse K, Verbist J, Peeters P. Bosiers M, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2010 Feb;51(1):115-9. J Cardiovasc Surg (Torino). 2010. PMID: 20081767 Free article. Review.
In lower extremity PTAs intraluminal is better than subintimal.
Bosiers M, Deloose K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P. Bosiers M, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2012 Apr;53(2):223-7. J Cardiovasc Surg (Torino). 2012. PMID: 22456645 Review.
Refining stent technologies for femoral interventions.
Bosiers M, Deloose K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P. Bosiers M, et al. Among authors: keirse k. J Cardiovasc Surg (Torino). 2012 Aug;53(4):465-73. J Cardiovasc Surg (Torino). 2012. PMID: 22854526 Review.
52 results